J&J settles Ohio lawsuits for $20m as opioid litigation trai...

Johnson & Johnson has managed to put opioid litigation in Ohio behind it with a $20 million settlement, saying that will

J&J gets okay for a third first-line Darzalex combo in US

FDA approves J&J's prostate cancer drug Erleada in new use, ...

The FDA has approved Johnson & Johnson’s prostate cancer drug Erleada (apalutamide) for patients whose prostate cancer has spread.

J&J filing aims Tremfya at crowded psoriatic arthritis marke...

Janssen's MS pill outshines Sanofi's Aubagio in phase 3 tria...

Johnson & Johnson’s Janssen unit has announced phase 3 results showing that its ponesimod tablet outperformed Sanofi’s Aubagio pill in adults with relapsing multiple sclerosis.

J&J gets Stelara okay in Europe for ulcerative colitis